Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HSGX

Histogenics (HSGX) Stock Price, News & Analysis

Histogenics logo

About Histogenics Stock (NASDAQ:HSGX)

Advanced Chart

Key Stats

Today's Range
$0.94
$1.02
50-Day Range
$0.16
$3.07
52-Week Range
$0.08
$1.43
Volume
4.44 million shs
Average Volume
9.06 million shs
Market Capitalization
$93.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HSGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogenics and its competitors with MarketBeat's FREE daily newsletter.

HSGX Stock News Headlines

Traphaco JSC TRA
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Headlines

HSGX Stock Analysis - Frequently Asked Questions

Histogenics Corp (NASDAQ:HSGX) released its quarterly earnings results on Thursday, August, 9th. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.10.

Histogenics (HSGX) raised $60 million in an initial public offering on Wednesday, December 3rd 2014. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Cowen and Company, Needham & Company and Canaccord Genuity acted as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogenics investors own include Interpace Biosciences (IDXG), Verastem (VSTM), Progenics Pharmaceuticals (PGNX), Novavax (NVAX), SCYNEXIS (SCYX), Ocular Therapeutix (OCUL) and OPKO Health (OPK).

Company Calendar

Last Earnings
8/09/2018
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:HSGX
CIK
1372299
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.64 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-34.96%
Return on Assets
18.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.05
Quick Ratio
4.05

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-99.36

Miscellaneous

Outstanding Shares
94,599,000
Free Float
N/A
Market Cap
$93.99 million
Optionable
Not Optionable
Beta
3.10
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:HSGX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners